retatrutide clinical trials brazil Phase 3: 60% Achieved Surgical-Level Weight Loss Lilly's 'triple G' agonist triumphs

Limited evidence also points to their effects on anxiety and cognitive functioning in dementia, but these findings were inconclusive

Treatment typically begins with a low starter dose (0.25 mg weekly for 4 weeks), followed by gradual increases (0.5 mg, then up to 12 mg weekly for Ozempic, or up to 2.4 mg for Wegovy), depending on tolerability and clinical response

Inspection of the trajectory of weight loss with time showed that weight loss with retatrutide was evident after 4-8 weeks and progressed with no evidence of plateau to the end of follow-up at 48 weeks [3]

Schedule your appointment today with Prime Heart and Vascular and let us help you keep your heart strong and healthy.